Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Nugent, David ^a   Vanderkerchove, Patrick ^b   Hughes, Edward ^c   Arnot, M ^d   Lilford, Richard ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b WALSGRAVE HOSPITAL   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d Warwick Medical School ^*  (New Zealand)

^e UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; COMPLICATION; FEMALE; HUMAN; INFERTILITY; OVARIAN HYPERSTIMULATION SYNDROME; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); URINE;

FOLLITROPIN; GONADORELIN; GONADOTROPIN;

FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991212424     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000410.pub2     Document Type: Review

References (58)

1. Bachus K, Hughes C, Haney A, Dodson W. The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotrophin with and without leuprolide acetate. Fertility & Sterility 1990;54:27-31.
2. Buckler H, Critchley H, Cantrill J, Shalet S, Anderson D, Robertson W. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome. Clinical Endocrinology 1993;38:209-17.
3. Fleming R, Coutts J. LHRH analogues for ovulation induction, with particular reference to polycystic ovary syndrome. Balliere's Clinical Obstetrics and Gynaecology 1988;2:677-87.
4. Abdel Gadir A, Mowafe R, Anaser H, Alrashid A, Alonezi O, Shaw R. Ovarian electrocautery versus human menopausal gonadotropins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clinical Endocrinology 1990;33:585-92.
5. Homburg R, Eshel A, Kilborn J, Adams J, Jacobs H. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Human Reproduction 1990;5:32-5.
6. Hompes P, van Weissenbruch M, Burger C, Schoemaker J. The additional use of buserelin in hMG-hCG ovulation induction in PCO: a double blind controlled study. In: R Rolland, DR Chadha, WNP Willemsen, AG Hoechst editor(s). Gonadotropin Down-Regulation in Gynecological Practice. New York: Liss, 1986:391-9.
7. Jacobs H, Porter R, Eshel A, Craft I. Profertility uses of LHRH agonist analogues. LHRH and its analogues; contraceptive and therapeutic application. Vol. part II, Lancaster: MTP Press, 1987:303-19.
8. Larsen T, Larsen J, Schioler V, Bostofte E, Felding C. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovary syndrome. Fertility & Sterility 1990;53:426-31.
9. McFaul P, Traub A, Sheridan B, Leslie H. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment. International Journal of Fertility 1989;34:194-8.
10. McFaul P, Traub A, Thompson W. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin. Fertility & Sterility 1990;53:792-7.
11. Quartero H, Dixon J, Westwood O, Hicks B, Chapman M. Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low-dose pulsatile administration and i.m. injections. Human Reproduction 1989;4:247-9.
12. Rossmanith W, Sterzik K, Wolf A. Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: succesful induction of ovulation in patients with polycystic ovarian disease. International Journal of Fertility 1987;32:460-6.
13. Sagle M, Hamilton-Fairley D, Kiddy D, Franks S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertility & Sterility 1991;55:56-60.
14. Seibel M, McArdle C, Smith D, Taymor M. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertility & Sterility 1985;43:703-8.
15. Buvat J, Buvat-Herbaut M, Marcolin G, Dehaene J, Verbecq P, Renouard O. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertility & Sterility 1989;52:553-9.
16. Buvat J, Buvat-Herbaut M. Sydrome des ovaires polycystiques: induction de l'ovulation par les gonadotrophines. Contraception, Fertilité, Sexualité 1989;17:337-42.
17. Buvat J, Buvat-Herbaut M, Marcolin G, Verbecq P. Contribution of pure FSH in ovulation induction excluding CContribution of pure FSH in ovulation induction excluding fertilization in vitro [Apport de la FSH pure dans l'induction de l'ovulation hors fecondation in vitro]. Revue Francaise de Gynecologie et d Obstetrique et d Obstetrique. 86(2):91-6, 1991 Feb 15. 1991;86(2):91-6.
18. Dodson W, Hughes C, Whitesides D, Haney A. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. Journal of Clinical Endocrinology 1987;65:95-100.
19. Dodson W, Hughes C, Yancy S, Haney A. Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome. Fertility & Sterility 1989;52:915-8.
20. Lanzone A, Fulghesu A, Villa P, Guida C, Guido M, Nicoletti M, Caruso A, Mancuso S. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertility & Sterility 1994;62:35-41.
21. McFaul P, Traub A, Thompson W. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome. Acta Europaea Fertilitatis 1989;20:157-61.
22. Prelevic G, Ginsburg J, Maletic D, Hardiman P, Okolo S, Balint-Peric L, Thomas M, Orskov H. The effects of somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Human Reproduction 1995;10:28-32.
23. Venturoli S, Paradisi R, Fabbri R, Magrini O, Porcu E, Flamigni C. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstetrics and Gynecology 1984;63:6-11.
24. Balen A, Tan S, Jacobs H. Hypersecretion of luteinising hormone-a significant cause of subfertility and miscarriage. British Journal of Obstetrics and Gynaecology 1993;100:1082-9.
25. Balen A, Braat D, West C, Patel A, Jacobs H. Cumulative conception and livebirth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction. Human Reproduction 1994;9:1563-70.
26. Botting B, Macfarlane A, Price F. Three, four or more: A study of triplet and higher order births. London: HMSO, 1990.
27. Brown J, Evans J, Adey F, Taft H, Townsend L. Factors involved in the induction of fertile ovulation with human gonadotrophins. Journal of Obstetrics and Gynaecology of the British Commonwealth 1969;76:289-307.
28. Brown J. Pituitary control of ovarian function-concepts derived from gonadotrophin therapy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1978;18:47-54.
29. Chang J, Laufer L, Meldrum D, DeFazio J, Lu J, Vale W, et al. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotrophin-releasing hormone agonist. Journal of Clinical Endocrinology 1983;56:897-903.
30. The ESHRE Capri Workshop. Female infertility: treatment options for complicated cases. Human Reproduction 1997;12:1191-6.
31. Farhi J, West C, Patel A, Jacobs H. Treatment of anovulatory infertility: the problem of multiple pregnancy. Human Reproduction 1996;11:429-34.
32. Fleming R, Black W, Coutts J. Effects of LH suppression in polycystic ovary syndrome. Clinical Endocrinology 1985;23:683-8.
33. Fleming R, Coutts J. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotrophin suppression. Fertility & Sterility 1986;45:226-30.
34. Forman R, Frydman R, Egan D. Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin releasing hormone for in vitro fertilisation: a European series and a proposal for prevention. Fertility & Sterility 1990;53:502-9.
35. Gadir AA, Mowafi RS, Alnaser HMI, Alrashid AH, Shaw RW. Ovarian electrocautery versus hMG and pure FSH therapy in the treatment of of patients with polycystic ovarian disease. Clinical Endocrinology 1990;33:585-92.
36. Garel G, Salobir C, Blondel B. Psychological consequences of having triplets: a 4-year follow-up study. Fertility & Sterility 1997;67:1162-5.
37. Golan A, Ron-El R, Herman A. Ovarian hyperstimulation syndrome: an update review. Obstetrical Gynecological Durvey 1989;44:430-40.
38. Hackeloer B, Fleming R, Robinson H, Adam A, Coutts J. Correlation of ultrasonic and endocrinological assessment of follicular development. American Journal of Obstetrics and Gynecology 1979;135:122-8.
39. Hammond M, Halme J, Talbert L. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstetrics and Gynecology 1983;62:196-202.
40. Homburg R, Armar N, Eshel A, Adams J, Jacobs H. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 1988;297:1024-6.
41. Howles C, MacNamee M, Edwards R, Goswamy R, Steptoe P. Effect of high tonic levels of LH on outcome of in-vitro fertilisation. Lancet 1986;ii:521-2.
42. Kemmann E, Brandeis V, Shelden R, Nosher J. The initial experience with the use of a portable pump in the delivery of human menopausal gonadotropins. Fertility & Sterility 1983;40:448-53.
43. Levene M, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. The British Association of Perinatal Medicine. British Journal of Obstetrics and Gynaecology 1992;99:607-13.
44. Navot D, Bergh P, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility & Sterility 1992;58:249-61.
45. Out H, Driessen S, Mannaerts B, Coelingh Bennick H. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertility & Sterility 1997;68:138-42.
46. Raj S, Thompson I, Berger M, Taymor M. Clinical aspects of polycystic ovary syndrome. Obstetrics and Gynecology 1977;49:552-6.
47. Regan L, Owen E, Jacobs H. Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 1990;336:141-4.
48. Reissmann T, Felberbaum R, Diedrich K, Engel J, Comaru-Schally A, Schally A. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Human Reproduction 1995;10:1974-81.
49. Schenker J, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertility & Sterility 1978;30:255-68.
50. Stanger J, Yovich J. Failure of human oocyte release at ovulation. Fertility & Sterility 1984;41(6):827-32.
51. Stanger J, Yovich J. Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. British Journal of Obstetrics and Gynaecology 1985;92:385-93.
52. Tartagni M, Diaferia A, Nicastri P, Loizzi P. Induction of multifollicular growth in patients non responding to clomiphene citrate and gonadotrophins or gonadotrophins only. Clinical and Experimental Obstetrics and Gynecology 1995;22:315-20.
53. Van Dessel H, Donderwinkel P, Coelingh Bennink H, Fauser B. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome. Human Reproduction 1994;9:55-6.
54. van Santbrink E, Fauser B. Urinary follicle stimulating hormone for normogonadotrophic clomiphene-resistant infertility: Prospective, randomized comparison between low dose step-up and step-down dose regimens. Journal of Clinical Endocrinology and Metabolism 1997;82:3597-602.
55. Wang C, Gemzell C. The use of human gonadotrophin for the induction of ovulation in women with polycystic ovarian disease. Fertility & Sterility 1980;33:479-86.
56. Yen S, Tsai C, Naftolin F, Vandenberg G, Ajabor L. Pulsatile patterns of gonadotrophin release in patients with and without ovarian function. Journal of Clinical Endocrinology and Metabolism 1972;34:671-5.
57. Zarte A, Herdmandez-Ayup S, Rios-Montiel A. Treatment of anovulation in the Stein-Leventhal syndrome. Analysis of ninety cases. Fertility & Sterility 1971;22:188-93.
58. Zeleznik A, Kubik C. Ovarian responses in macaques to pulsatile infusion of follicle stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH. Endocrinology 1986;119:2025-30.